Skip to main content

Day: September 1, 2021

Caladrius Biosciences Announces Appointment of Kristen K. Buck, M.D., as Chief Medical Officer

BASKING RIDGE, N.J., Sept. 01, 2021 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced the appointment of Dr. Kristen K. Buck as the Company’s Chief Medical Officer (“CMO”). Dr. Buck joins Caladrius from ICON plc (“ICON”), a global provider of drug and device development and commercialization services to the pharmaceutical, biotechnology and medical device industries. During her time at ICON, Dr. Buck served as its CMO, where she represented the company’s position on key scientific, ethical, and medical governance matters, provided guidance and oversight to the medical and scientific groups, and led the Drug Development Services group. Prior to that,...

Continue reading

Atos completes the acquisition of German cryptography specialist cryptovision and strengthens its cybersecurity product line

Paris, France and Munich, Germany – September 1, 2021 – Atos today announced that it has completed the acquisition of cv cryptovision GmbH, a leader in advanced cryptographic products and solutions for securing digital identities. In addition to bringing new technical capabilities and cybersecurity products to the Group’s portfolio, the acquisition will enable Atos to expand its business in the public sector and defense market in Europe, to strengthen its position in global government eID initiatives, and to grow its footprint in emerging IoT markets. cryptovision designs, develops and implements cryptography solutions, software and hardware products which are made in Germany and meet the most demanding regulations, certifications and security standards (accredited by the German Federal Office for Information Security and NATO; certified...

Continue reading

Laurentian Bank Financial Group reports third quarter 2021 results

The financial information reported herein is based on the condensed interim consolidated (unaudited) information for the three-month period ended July 31, 2021, and has been prepared in accordance with International Financial Reporting standards (IFRS), as issued by the International Accounting Standards Board (IASB). All amounts are denominated in Canadian dollars. The Laurentian Bank of Canada and its entities are collectively referred to as Laurentian Bank Financial Group (the “Group” or the “Bank”) and provide deposit, investment, loan, securities, trust and other products or services.Highlights of third quarter 2021 (compared with third quarter 2020)Reported net income of $62.1 million, compared with $36.2 million. Adjusted net income(1) of $59.0 million, compared with $47.1 million. Diluted earnings per share of $1.32, compared...

Continue reading

Entourage Health Announces New Ticker Symbol on U.S.-Based OTCQX Market as ‘ETRGF’ Effective September 1, 2021

TORONTO, Sept. 01, 2021 (GLOBE NEWSWIRE) — Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX: ETRGF), (formerly OTCQX: WDDMF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands, announced that effective at market open on September 1, 2021, the OTCQX market ticker symbol for the Company’s common shares will change from “WDDMF” to “ETRGF”. The OTCQX symbol change is consistent with the Company’s rebranding from WeedMD Inc. to Entourage Health Corp. announced earlier this year. The Company’s common shares continue to trade primarily on the TSX Venture Exchange (“TSXV”) under the symbol “ENTG” and Frankfurt Stock Exchange (“FSE”) under the symbol ”4WE”. About Entourage Health Corp. Entourage Health Corp. (formerly WeedMD Inc.) is the publicly traded...

Continue reading

Aleafia Health Announces Appointment of David Pasieka to Board of Directors

TORONTO, Sept. 01, 2021 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the appointment of David Pasieka to its board of directors. Mr. Pasieka is a seasoned public company executive and director with extensive board level experience in finance & audit, risk management, and ESG. Mr. Pasieka was a long-standing c-suite executive at Algonquin Power & Utilities, overseeing its growth into a global energy leader and member of the S&P/TSX 60 Index of Canada’s largest companies. He also served as entrepreneur in residence at the MaRS Discovery District, North America’s largest innovation hub supporting the growth of over 1,400 Canadian startups. He holds an MBA from York University along with a Chartered Director designation. Concurrent with the...

Continue reading

Lakewood Exploration Prepares for Phase I Drill Program with Underground Rehabilitation Now Underway at the Silver Strand Mine

Figure 1Underground scoop moving blasted rock at Silver StrandFigure 2Underground drilling underway to establish new drill bay at Silver StrandVANCOUVER, British Columbia, Sept. 01, 2021 (GLOBE NEWSWIRE) — Lakewood Exploration Inc. (CSE: LWD) (the “Company” or “Lakewood“) is pleased to announce that it has engaged Coeur d’Alene Mining Contractors to perform minor rehabilitation work ahead of a Phase I drill campaign, which is expected to commence in the coming weeks at the Company’s flagship past-producing Silver Strand Mine in the Coeur d’Alene mining district of Idaho. The contractor will bring the mine into United State Mine Safety and Health Administration (MSHA) compliance, complete rehabilitation works, develop 45 feet of underground drift (see Figure 1) and open...

Continue reading

ParcelPal Announces Signing of Definitive Agreements for its First United States Acquisition

VANCOUVER, British Columbia, Sept. 01, 2021 (GLOBE NEWSWIRE) — ParcelPal Logistics Inc. (the “Company” or “ParcelPal”), (OTC:PTNYF) (CSE:PKG) (FSE:PT0) is pleased to announce that, subsequent to the previously announced letter of intent on July 14, the parties related to the Company’s acquisition of its first United States delivery service company (“Acquiree”) have signed the definitive agreements related thereto and anticipate closing within a week. This transaction effectively nearly doubles both the Company’s annual revenue and size of ParcelPal, which is additionally significant since it marks the first such acquisition in the history of the Company. The total purchase price (the “Purchase Price”) was $3.1 million USD, consisting of 60% cash and 40% in restricted shares of ParcelPal’s common stock. ParcelPal and Acquiree also...

Continue reading

Brickell Biotech Expands Leadership Team, Appointing Dr. Monica Luchi as Chief Medical Officer

Dr. Luchi brings over 20 years of immunotherapeutic and drug development experience and will lead Brickell’s clinical development strategy and medical affairs functions BOULDER, Colo., Sept. 01, 2021 (GLOBE NEWSWIRE) — Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of dermatologic, autoimmune and other debilitating diseases, today announced that it has appointed Monica Luchi, MD, FACR, MBA to the newly created role of Chief Medical Officer. In this new role, Dr. Luchi will oversee the Company’s clinical development strategy and medical affairs functions. “We are delighted to have Dr. Luchi join our team at this transformative point in our Company’s...

Continue reading

Olink to present at two upcoming investor conferences

UPPSALA, Sweden, Sept. 01, 2021 (GLOBE NEWSWIRE) — Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Jon Heimer, CEO, and Oskar Hjelm, CFO, will participate in the following virtual investor conferences:Goldman Sachs Eighteenth Annual European Medtech and Healthcare Services ConferenceFireside chat on Wednesday, September 8th at 10:30 a.m. ETMorgan Stanley 19th Annual Global Healthcare ConferenceFireside chat on Friday, September 10th at 8:00 a.m. ETLive and archived webcasts of the events will be available on the “Investors” section of the Company’s website at https://investors.olink.com/investor-relations. About Olink Holding Olink Holding AB (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries...

Continue reading

Aravive to Participate in Fireside Chat at H.C. Wainwright 23rd Annual Global Investment Conference

HOUSTON, Sept. 01, 2021 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a clinical-stage oncology company developing innovative therapeutics to treat life-threatening diseases, today announced that Gail McIntyre, Ph.D., DABT, Chief Executive Officer of Aravive, and Reshma Rangwala, M.D., Ph.D., Chief Medical Officer of Aravive, will participate in a virtual fireside chat at the H.C. Wainwright 23rd Annual Global Investment Conference taking place September 13-15, 2021. The Company’s presentation will be available for viewing on September 13, 2021 at 7:00 AM ET. Aravive will also participate in one-on-one meetings at the conference. This meeting is being held virtually, and a live webcast will be accessible on the Events & Presentations page of www.aravive.com. An archived replay of the webcast will be available for 90 days...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.